PSNL Personalis Inc

USD 1.45 0.02 1.398601
Icon

Personalis Inc (PSNL) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.45

+0.02 (+1.40)%

USD 0.08B

0.21M

USD 2.30(+58.62%)

N/A

Icon

PSNL

Personalis Inc (USD)
COMMON STOCK | NSD
USD 1.45
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.08B

N/A

USD 1.45

Personalis Inc (PSNL) Stock Forecast

USD 2.30
(+58.62%)

Based on the Personalis Inc stock forecast from 1 analysts, the average analyst target price for Personalis Inc is USD 2.30 over the next 12 months. Personalis Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Personalis Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Personalis Inc’s stock price was USD 1.45. Personalis Inc’s stock price has changed by -3.97% over the past week, -3.33% over the past month and -44.44% over the last year.

No recent analyst target price found for Personalis Inc
No recent average analyst rating found for Personalis Inc

Company Overview Personalis Inc

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor a...Read More

https://www.personalis.com

1330 O?Brien Drive, Menlo Park, CA, United States, 94025

223

December

USD

USA

Adjusted Closing Price for Personalis Inc (PSNL)

Loading...

Unadjusted Closing Price for Personalis Inc (PSNL)

Loading...

Share Trading Volume for Personalis Inc Shares

Loading...

Compare Performance of Personalis Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PSNL

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Personalis Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
TMO
Thermo Fisher Scientific Inc +10.55 (+1.85%) USD219.76B 37.30 22.26

ETFs Containing PSNL

Symbol Name PSNL's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Personalis Inc (PSNL) Stock

Based on ratings from 1 analysts Personalis Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on PSNL's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for PSNL is USD 2.30 over the next 12 months. The maximum analyst target price is USD 2.3 while the minimum anlayst target price is USD 2.3.

PSNL stock's Price/Earning ratio is 53.95. Our analysis grades PSNL stock's Price / Earning ratio at F. This means that PSNL stock's Price/Earning ratio is above 70% of the stocks in the Diagnostics & Research sector in the NSD exchange. Based on this PSNL may be a overvalued for its sector.

The last closing price of PSNL's stock was USD 1.45.

The most recent market capitalization for PSNL is USD 0.08B.

Based on targets from 1 analysts, the average taret price for PSNL is projected at USD 2.30 over the next 12 months. This means that PSNL's stock price may go up by +58.62% over the next 12 months.

We can't find any ETFs which contains Personalis Inc's stock.

As per our most recent records Personalis Inc has 223 Employees.

Personalis Inc's registered address is 1330 O?Brien Drive, Menlo Park, CA, United States, 94025. You can get more information about it from Personalis Inc's website at https://www.personalis.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...